Soloman Shah, MD, received his bachelor’s degree from the University of Virginia and doctor of medicine from Eastern Virginia Medical School. For more than 15 years, Dr. Soloman Shah has practiced at Gastrointestinal Medicine Associates, PC, in Vienna, Virginia, where he maintains a professional interest in treating and diagnosing liver disease.
Liver failure is when the liver has already lost or is in the process of losing its function; it’s a life-threatening condition demanding urgent medical care. Symptoms of liver failure include fatigue, diarrhea, loss of appetite, and nausea. Unfortunately, these symptoms can have multiple causes, and it can be difficult to know if they are related to the liver failing.
As liver failure progresses, the condition becomes more dangerous, and the symptoms more severe. Disorientation, confusion, and extreme sleepiness are commonly observed as the condition worsens. Typically, a part of the liver that still functions will try to be saved by medical professionals; however, this is not always possible, and a liver transplant may be required.
Soloman Shah, MD, has practiced medicine at Gastrointestinal Medicine Associates, PC, in Vienna, Virginia, for over 15 years. With multiple publications to his credit, Dr. Soloman Shah is a Diplomate of the National Board of Medical Examiners and American Board of Internal Medicine and focuses on diagnosing and treating liver disorders.
A slowly progressing disease, cirrhosis is the replacement of healthy liver tissue by scar tissue. As scar tissue can impede blood flow, slowing down the processing of hormone drugs, naturally produced toxins, and nutrients, this process can eventually prevent the liver from functioning properly.
Alcohol abuse, fatty liver, and hepatitis C are the main culprits of developing cirrhosis. However, anything that potentially damages the liver can lead to cirrhosis, including diabetes, obesity, and viral infections. Less likely causes include parasitic infections, increased exposure to environmental toxins, and certain prescription drugs.
Cirrhosis has been identified as the 12th principal cause of death from a disease.
Since 1999, Soloman Shah, MD, has worked as a physician at the Gastrointestinal Medicine Associates PC in Reston, Virginia. For over 15 years, Dr. Soloman Shah has focused on liver disorders–particularly cirrhosis and hepatitis. Other liver disorders include more serious ones, such as tyrosinaemia type I.
Baylor College of Medicine and its researchers found a way to delete a disease-associated gene from tyrosinaemia type I and transform it into a benign state.
According to Dr. Karl-Dimiter Bissig, an assistant professor at the Center for Cell and Gene Therapy, the process is called metabolic pathway reprogramming. It is a relatively a new concept that focuses on the disease-associated gene rather than the disease-causing gene.
The simple explanation is that Dr. Bissig’s team rewrote the metabolic pathway to avoid having to encounter the areas of the genes that cause the tyrosinaemia type I. The usual treatment plan for the disease is drug therapy; however, the need for drugs was eliminated when the reprogramming was used on mice.